The invention relates to the identification of pharmacological agents to be used in the treatment of Alzheimer's disease and related pathological conditions. Methods and compositions for treatment of conditions caused by amyloidosis, A-mediated ROS formation, or both, such as Alzheimer's disease, are disclosed.

 
Web www.patentalert.com

< Alternatively spliced circulating tissue factor

< Combination comprising N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine and telomerase inhibitor

> Methods of coating a device using anti-thrombin heparin

> Storage-stable, liquid fibrinogen formulation
~ 00262